Across TCGA pan-cancer cohorts, ENG mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated ENG data layer compared with 29 for mass-spec protein and 5 for mutation status.
The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher ENG mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated ENG expression acts as an unfavorable survival marker, although some lineages such as PDAC show a favorable association.
PDAC, UCEC, and GBM are the cancer types where ENG mass-spec protein most reproducibly stratifies survival.